IL197871D0 - Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers - Google Patents

Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers

Info

Publication number
IL197871D0
IL197871D0 IL197871A IL19787109A IL197871D0 IL 197871 D0 IL197871 D0 IL 197871D0 IL 197871 A IL197871 A IL 197871A IL 19787109 A IL19787109 A IL 19787109A IL 197871 D0 IL197871 D0 IL 197871D0
Authority
IL
Israel
Prior art keywords
micro
embedded
compounds
dosage forms
solid dosage
Prior art date
Application number
IL197871A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US85185206P priority Critical
Priority to US95440107P priority
Priority to PCT/EP2007/060542 priority patent/WO2008043701A1/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL197871D0 publication Critical patent/IL197871D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
IL197871A 2006-10-13 2009-03-26 Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers IL197871D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US85185206P true 2006-10-13 2006-10-13
US95440107P true 2007-08-07 2007-08-07
PCT/EP2007/060542 WO2008043701A1 (en) 2006-10-13 2007-10-04 Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers

Publications (1)

Publication Number Publication Date
IL197871D0 true IL197871D0 (en) 2009-12-24

Family

ID=38857877

Family Applications (1)

Application Number Title Priority Date Filing Date
IL197871A IL197871D0 (en) 2006-10-13 2009-03-26 Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers

Country Status (16)

Country Link
US (1) US20080107725A1 (en)
EP (1) EP2079447A1 (en)
JP (1) JP2010505901A (en)
KR (1) KR20090053858A (en)
AR (1) AR063259A1 (en)
AU (1) AU2007306402A1 (en)
BR (1) BRPI0719880A2 (en)
CA (1) CA2665604A1 (en)
CL (1) CL2007002921A1 (en)
IL (1) IL197871D0 (en)
MX (1) MX2009003516A (en)
NO (1) NO20091274L (en)
PE (1) PE20081461A1 (en)
RU (1) RU2009117711A (en)
TW (1) TW200824709A (en)
WO (1) WO2008043701A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
EP2582709B1 (en) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CA2863409A1 (en) * 2012-02-16 2013-08-22 Teva Pharmaceutical Industries Ltd. N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof
JO3339B1 (en) * 2012-09-11 2019-03-13 Shanghai Inst Pharmaceutical Ind Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it
EP3228307A1 (en) * 2016-04-05 2017-10-11 Sandoz Ag Solid dispersion comprising opioid antagonists

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
DE19515972A1 (en) * 1995-05-02 1996-11-07 Bayer Ag Medicinal preparations with controlled release, and processes for their preparation
WO1998030208A1 (en) * 1997-01-10 1998-07-16 Abbott Laboratories Tablet for the controlled release of active agents
DE19732903A1 (en) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet formulation for the treatment of the intestinal tract
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
EP1027886B1 (en) * 1999-02-10 2008-07-09 Pfizer Products Inc. Pharmaceutical solid dispersions
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
BR0110492A (en) * 2000-05-03 2003-04-08 Hoffmann La Roche A compound, a pharmaceutical composition comprising such a compound, a process for preparing a pharmaceutical composition, using a compound and a process for preparing a compound.
AU6350601A (en) * 2000-05-18 2001-11-26 Therics Inc Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form
EP1458382A1 (en) * 2001-12-21 2004-09-22 Novo Nordisk A/S Amide derivatives as gk activators
AU2003221140B9 (en) * 2002-03-26 2009-07-30 Banyu Pharmaceutical Co., Ltd. Novel aminobenzamide derivative
WO2003090717A1 (en) * 2002-04-23 2003-11-06 Nanotherapeutics, Inc Process of forming and modifying particles and compositions produced thereby
PE20040801A1 (en) * 2002-12-12 2004-11-25 Hoffmann La Roche Pyrazine derivatives and 5-substituted pyridine as glucokinase activators
WO2005030257A2 (en) * 2003-09-30 2005-04-07 Solubest Ltd. Water soluble nanoparticles inclusion complexes

Also Published As

Publication number Publication date
CA2665604A1 (en) 2008-04-17
EP2079447A1 (en) 2009-07-22
AU2007306402A1 (en) 2008-04-17
JP2010505901A (en) 2010-02-25
BRPI0719880A2 (en) 2014-06-10
MX2009003516A (en) 2009-04-14
NO20091274L (en) 2009-05-28
KR20090053858A (en) 2009-05-27
US20080107725A1 (en) 2008-05-08
PE20081461A1 (en) 2008-10-18
CL2007002921A1 (en) 2008-05-30
RU2009117711A (en) 2010-11-20
TW200824709A (en) 2008-06-16
WO2008043701A1 (en) 2008-04-17
AR063259A1 (en) 2009-01-14

Similar Documents

Publication Publication Date Title
TWI455735B (en) Manifold for use in medicament dispenser
HUE038022T2 (en) Non-mucoadhesive film dosage forms
EP2056792A4 (en) Drug delivery systems comprising solid solutions of weakly basic drugs
EP1978892A4 (en) Drug delivery treatment device
PL2058020T3 (en) Devices for medicament delivery
HK1122508A1 (en) Nanoparticles for protein drug delivery
PL2457562T3 (en) Zero-order modified release solid dosage forms
IL190749A (en) Anti-misuse microparticulate oral pharmaceutical form
ZA201002014B (en) Drug delivery system
IL184563A (en) Pharmaceutical foam formulations and their uses
PT2484346T (en) Pharmaceutical compositions
EP1885414A4 (en) Device for delivering medicament
EP2001497A4 (en) Pharmaceutical compositions
DK2399580T3 (en) Pharmaceutical dosage forms
EP1933881A4 (en) Solid polymer delivery compositions and methods for use thereof
ZA200807006B (en) Drug delivery device
IL183295D0 (en) Drug delivery device
EP1922019A4 (en) Tri-block copolymers for nanosphere-based drug delivery
EP2132133A4 (en) Particulate drug delivery
IL198911D0 (en) Drug delivery
PL2041139T3 (en) Pharmaceutical compounds
ZA201002255B (en) Orodispersible tablets
EP1778196A4 (en) Pharmaceutical dosage forms including rasagiline
IL206159A (en) Oral pharmaceutical dosage forms
IL207128D0 (en) Pharmaceutical dosage form